Pathophysiology, clinical manifestations and therapy of consumption-coagulopathy (“Verbrauchskoagulopathie”)
- 30 September 1967
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 20 (3) , 381-391
- https://doi.org/10.1016/0002-9149(67)90062-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Zur thrombolytischen Therapie des frischen Herzinfarktes. I. Einführung, Behandlungspläne, allgemeine klinische ErgebnisseDeutsche Medizinische Wochenschrift (1946), 1966
- Induced Hypersensitivity to ColdScience, 1965
- Prevention of “Irreversible” Hemorrhagic Shock with FibrinolysinAnnals of Surgery, 1963
- RETICULOENDOTHELIAL CLEARANCE OF CIRCULATING FIBRIN IN THE PATHOGENESIS OF THE GENERALIZED SHWARTZMAN REACTIONThe Journal of Experimental Medicine, 1962
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. I. THE SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS*Journal of Clinical Investigation, 1962
- Untersuchungen zur Frage der Gerinnungsstörung beim Sanarelli-Shwartzman-Phänomen (sog. generalisierten Shwartzman-Phänomen) des KaninchensZeitschrift für Die Gesamte Experimentelle Medizin, 1959
- Viscous Metamorphosis of Blood Platelets and Clot RetractionVox Sanguinis, 1956
- The Physiological Disturbances Produced by EndotoxinsAnnual Review of Physiology, 1954
- Zur Prothrombinbildung in der LeberHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1953
- Ueber hyaline Ballen und Thromben in den Gehirngefässen bei acuten InfectionskrankheitenVirchows Archiv, 1892